Noble VictoriesNoble Victories🃏All Larvesta cards
Ask about Larvesta
Larvesta #20 Pokémon card from Noble Victories

Larvesta 20/101

Noble Victories

Find this card on eBay

Affiliate link · we may earn commission

Larvesta #20 from Noble Victories currently trades at $0.87 raw, with PSA 10 copies reaching $35.03 — a 40.3x grade premium.
Current Prices (USD)
Ungraded
$0.87
PSA 7
$12.16
PSA 8
$12.16
PSA 9
$12.16
PSA 10
$35.03
ACE 10
BGS 10 Black
$230.00
CGC 10 Pristine
$38.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Larvesta 20/101 from Noble Victories has a current raw market value of $0.87.

Current raw value
$0.87
PSA 9 value
$12.16
PSA 10 value
$35.03
PSA 10 premium vs raw
40.3× raw
View all cards from Noble Victories
Collector Intel
40.3x
Raw → PSA 10
High-risk grade
14.0x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 40x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$35
PSA 10 Value
+$9
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1214.0x raw
PSA 10$3540.3x raw

Frequently asked questions

How much is Larvesta #20 from Noble Victories worth?+
Larvesta #20 from Noble Victories is currently worth Raw: $0.87, PSA 9: $12.16, PSA 10: $35.03 based on recent sold listings. Prices update daily from real eBay sales.
Is Larvesta #20 worth grading?+
The PSA 10 price of $35.03 is 40.3× the raw price of $0.87. After a ~$25 grading fee, a PSA 10 result would net approximately $34.16 — assuming the card grades a 10.
Where do PokePrices Larvesta #20 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.